| The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy: 2014 Update LB Ramsey, SG Johnson, KE Caudle, CE Haidar, D Voora, RA Wilke, ... Clinical Pharmacology & Therapeutics 96 (4), 423-428, 2014 | 485 | 2014 |
| The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy RA Wilke, LB Ramsey, SG Johnson, WD Maxwell, HL McLeod, D Voora, ... Clinical Pharmacology & Therapeutics, 2012 | 401* | 2012 |
| Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition LB Ramsey, GH Bruun, W Yang, LR Treviño, S Vattathil, P Scheet, ... Genome Research 22 (1), 1-8, 2012 | 301 | 2012 |
| The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin‐Associated Musculoskeletal … RM Cooper‐DeHoff, M Niemi, LB Ramsey, JA Luzum, EK Tarkiainen, ... Clinical Pharmacology & Therapeutics, 2022 | 244 | 2022 |
| Genome-wide study of methotrexate clearance replicates SLCO1B1 LB Ramsey, JC Panetta, C Smith, W Yang, Y Fan, NJ Winick, PL Martin, ... Blood 121 (6), 898-904, 2013 | 236 | 2013 |
| Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance LB Ramsey, FM Balis, MM O'Brien, K Schmiegelow, JL Pauley, A Bleyer, ... The Oncologist, theoncologist. 2017-0243, 2017 | 215 | 2017 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin … CA Bousman, JM Stevenson, LB Ramsey, K Sangkuhl, JK Hicks, ... Clinical Pharmacology & Therapeutics, 2023 | 201 | 2023 |
| Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia LM Heltemes-Harris, MJL Willette, LB Ramsey, YH Qiu, ES Neeley, ... Journal of Experimental Medicine 208 (6), 1135-1149, 2011 | 199 | 2011 |
| NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells SW Paugh, EJ Bonten, D Savic, LB Ramsey, WE Thierfelder, P Gurung, ... Nature genetics 47 (6), 607-614, 2015 | 175 | 2015 |
| RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci SL Hewitt, B Yin, Y Ji, J Chaumeil, K Marszalek, J Tenthorey, ... Nature immunology 10 (6), 655-664, 2009 | 166 | 2009 |
| Combined Targeting of JAK2 and Bcl-2/Bcl-xL to Cure Mutant JAK2-Driven Malignancies and Overcome Acquired Resistance to JAK2 Inhibitors M Waibel, VS Solomon, DA Knight, RA Ralli, SK Kim, KM Banks, E Vidacs, ... Cell reports 5 (4), 1047-1059, 2013 | 151 | 2013 |
| HLA-DRB1* 07: 01 is associated with a higher risk of asparaginase allergies CA Fernandez, C Smith, W Yang, M Date, D Bashford, E Larsen, ... Blood, 2014 | 124 | 2014 |
| Influence of CYP2C19 metabolizer status on escitalopram/citalopram tolerability and response in youth with anxiety and depressive disorders SL Aldrich, EA Poweleit, CA Prows, LJ Martin, JR Strawn, LB Ramsey Frontiers in Pharmacology 10, 99, 2019 | 105 | 2019 |
| Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia D Bhojwani, R Darbandi, D Pei, LB Ramsey, W Chemaitilly, JT Sandlund, ... European Journal of Cancer 50 (15), 2685-2694, 2014 | 98 | 2014 |
| Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival CDS Katerndahl, LM Heltemes-Harris, MJL Willette, CM Henzler, ... Nature Immunology 18 (6), 694-704, 2017 | 96 | 2017 |
| B cell receptor basal signaling regulates antigen-induced Ig light chain rearrangements BR Schram, LE Tze, LB Ramsey, J Liu, L Najera, AL Vegoe, RR Hardy, ... The Journal of Immunology 180 (7), 4728-4741, 2008 | 86 | 2008 |
| Genome-wide analysis links NFATC2 with asparaginase hypersensitivity CA Fernandez, C Smith, W Yang, CG Mullighan, C Qu, E Larsen, ... Blood 126 (1), 69-75, 2015 | 80 | 2015 |
| Pharmacogenomic testing in child and adolescent psychiatry: an evidence-based review AM Wehry, L Ramsey, SE Dulemba, SA Mossman, JR Strawn Current problems in pediatric and adolescent health care 48 (2), 40-49, 2018 | 79 | 2018 |
| PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity G Stocco, W Yang, KR Crews, WE Thierfelder, G Decorti, M Londero, ... Human molecular genetics 21 (21), 4793-4804, 2012 | 78 | 2012 |
| Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing LH Cavallari, SL Van Driest, CA Prows, JR Bishop, NA Limdi, VM Pratt, ... Genetics in Medicine 21 (10), 2255-2263, 2019 | 72 | 2019 |
Jeffrey R. StrawnProfessor of Psychiatry and Pediatrics, University of CincinnatiPatvirtintas el. paštas uc.edu